Marlo Rencher

Dr. Marlo Rencher is CEO of Good Sweat, a social fundraising platform for charity sports participants—people who run, walk and move for a cause. She is also a business anthropologist interested in entrepreneurship, technology and culture. Follow her on Twitter at @marlorencher.

Recent posts

The Valley of Death and the Art of the Pitch
Imagine waking up each morning to a conundrum. You are a traveler making your way through a stark, unforgiving valley and you don’t know the way out. There is the sky... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Sponsored · Whitepaper
COVID-19 Special Report: Sustaining Clinical Research During the Crisis
Leveraging technology & expertise to ensure a continual journey from trials to treatments
PRA Health Sciences

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

AbbVie Wins First FDA Approval of Drug to Treat Uterine Fibroid Bleeds

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Forma Therapeutics Eyes IPO to Advance Sickle Cell, Prostate Cancer Drugs

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Variant Emerges With $16M to Find “Outlier Humans” to Reveal New Drugs

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

New Webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-Induced Liver Injury

Seres Therapeutics Taps Alkermes’s von Moltke as Chief Medical Officer

Lantern Pharma IPO File Illuminates Plan to “Rescue” Failed Cancer Drugs

War Paint to Bone Paint: MIT Spinout Aims to Transform Regenerative Meds

Xcelerating Life Sciences Philadelphia (interactive online event)

Xcelerating Life Sciences San Francisco (interactive online event)

Xcelerating Life Sciences Seattle

Marlo Rencher

Recent posts

The Valley of Death and the Art of the Pitch

Underwriters and Partners

Robert Langer reveals secrets to early-stage biotech success

COVID-19 Special Report: Sustaining Clinical Research During the Crisis

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

Xconomy on Demand

We offer a number of ways to subscribe for free!